These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27 related articles for article (PubMed ID: 14698169)
1. Molecular determinants of antagonist interactions with chemokine receptors CCR2 and CCR5. Dawson JRD; Wadman GM; Zhang P; Tebben A; Carter PH; Gu S; Shroka T; Borrega-Roman L; Salanga CL; Handel TM; Kufareva I bioRxiv; 2024 Feb; ():. PubMed ID: 38014122 [TBL] [Abstract][Full Text] [Related]
2. Palladium-Catalyzed Aminocyclization-Coupling Cascades: Preparation of Dehydrotryptophan Derivatives and Computational Study. Vaz B; Martínez C; Cruz F; Denis JG; de Lera ÁR; Aurrecoechea JM; Álvarez R J Org Chem; 2021 Jul; 86(13):8766-8785. PubMed ID: 34125552 [TBL] [Abstract][Full Text] [Related]
3. Pyrrolone Derivatives as Intracellular Allosteric Modulators for Chemokine Receptors: Selective and Dual-Targeting Inhibitors of CC Chemokine Receptors 1 and 2. Ortiz Zacarías NV; van Veldhoven JPD; Portner L; van Spronsen E; Ullo S; Veenhuizen M; van der Velden WJC; Zweemer AJM; Kreekel RM; Oenema K; Lenselink EB; Heitman LH; IJzerman AP J Med Chem; 2018 Oct; 61(20):9146-9161. PubMed ID: 30256641 [TBL] [Abstract][Full Text] [Related]
4. What Do Structures Tell Us About Chemokine Receptor Function and Antagonism? Kufareva I; Gustavsson M; Zheng Y; Stephens BS; Handel TM Annu Rev Biophys; 2017 May; 46():175-198. PubMed ID: 28532213 [TBL] [Abstract][Full Text] [Related]
5. Discovery, optimization, and pharmacological characterization of novel heteroaroylphenylureas antagonists of C-C chemokine ligand 2 function. Laborde E; Macsata RW; Meng F; Peterson BT; Robinson L; Schow SR; Simon RJ; Xu H; Baba K; Inagaki H; Ishiwata Y; Jomori T; Matsumoto Y; Miyachi A; Nakamura T; Okamoto M; Handel TM; Bernard CC J Med Chem; 2011 Mar; 54(6):1667-81. PubMed ID: 21341682 [TBL] [Abstract][Full Text] [Related]
6. Structural Analysis of Chemokine Receptor-Ligand Interactions. Arimont M; Sun SL; Leurs R; Smit M; de Esch IJP; de Graaf C J Med Chem; 2017 Jun; 60(12):4735-4779. PubMed ID: 28165741 [TBL] [Abstract][Full Text] [Related]
7. CCR2B receptor antagonists: conversion of a weak HTS hit to a potent lead compound. Forbes IT; Cooper DG; Dodds EK; Hickey DM; Ife RJ; Meeson M; Stockley M; Berkhout TA; Gohil J; Groot PH; Moores K Bioorg Med Chem Lett; 2000 Aug; 10(16):1803-6. PubMed ID: 10969972 [TBL] [Abstract][Full Text] [Related]